News|Articles|October 14, 2013

Recipham to Expand Lyophilization Capacity in Germany

Recipharm has invested EUR 32 million ($43 million) in its Wasserburg, Germany site to expand lyophilization capacity.

Recipharm will invest EUR 32 million ($43 million) in its Wasserburg, Germany site located near Munich to create a new building that will house a fourth production area adding to the three already in operation. This development will increase the company’s lyophilization capacity and automatic loading and unloading technology. The building will also have the flexibility to accommodate further production lines.  The number of employees will be increased from the current 282 to 320, and the new area is expected to be operational in 2016.
 
Source: Recipharm


Related to this article

AAPS PharmSci 360: CMC Strategies, Part 3
In a preview of their panel discussion at AAPS PharmSci 360 2026, Alfred Rumondor, PhD, AbbVie, and Swita Singh, PhD, Bristol Myers Squibb, discuss the implementation of risk-based approaches for CMC.